Hyperprogression of cutaneous T cell lymphoma after anti–PD-1 treatment

BACKGROUND: Immune checkpoint blockade is an emerging treatment for T cell non-Hodgkin’s lymphoma (T-NHL), but some patients with T-NHL have experienced hyperprogression with undetermined mechanisms upon anti–PD-1 therapy. METHODS: Single-cell RNA-Seq, whole-genome sequencing, whole-exome sequencing...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yumei, Hu, Simeng, Li, Ruoyan, Jin, Shanzhao, Liu, Fengjie, Liu, Xiangjun, Li, Yingyi, Yan, Yicen, Liu, Weiping, Gong, Jifang, Yang, Shuxia, Tu, Ping, Shen, Lin, Bai, Fan, Wang, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977500/
https://www.ncbi.nlm.nih.gov/pubmed/36649072
http://dx.doi.org/10.1172/jci.insight.164793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977500/
https://www.ncbi.nlm.nih.gov/pubmed/36649072
http://dx.doi.org/10.1172/jci.insight.164793

Ejemplares similares